Fluoroquinolone antibiotics: Adverse effects and safety profiles

被引：12

作者：

Dembry, LM

Farrington, JM

Andriole, VT

机构：

[1] Yale New Haven Hosp, New Haven, CT 06504 USA

[2] Yale Univ, Sch Med, New Haven, CT 06504 USA

来源：

INFECTIOUS DISEASES IN CLINICAL PRACTICE | 1999年 / 8卷 / 09期

关键词：

D O I：

10.1097/00019048-199912000-00008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：421 / 428

页数：8

共 38 条

[1]

ANDRIOLE VT, 1996, CURRENT MED, P148

[2]

ANDRIOLE VT, 1989, PRINCIPLES PRACTICE, P334

[3]

ANDRIOLE VT, 1998, INFECT DIS, P275

[4] INTERACTION OF OFLOXACIN AND WARFARIN [J].

BACIEWICZ, AM ;

ASHAR, BH ;

LOCKE, TW .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (12) :1223-1223

[5]

Ball P, 1998, QUINOLONES, 2ND EDITION, P1

[6] TOLERABILITY OF FLUOROQUINOLONE ANTIBIOTICS - PAST, PRESENT AND FUTURE [J].

BALL, P ;

TILLOTSON, G .

DRUG SAFETY, 1995, 13 (06) :343-358

[7]

Bergan T, 1998, QUINOLONES, 2ND EDITION, P143

[8]

Beringer PM, 1997, FORMULARY, V32, P926

[9] TEMAFLOXACIN SYNDROME - REVIEW OF 95 CASES [J].

BLUM, MD ;

GRAHAM, DJ ;

MCCLOSKEY, CA .

CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) :946-950

[10]

BRUCH K, 1987, INT J CLIN PHARM RES, V7, P195

← 1 2 3 4 →